Imbimbo, Martina http://orcid.org/0000-0003-2521-7540
Wetterwald, Laureline
Friedlaender, Alex
Parikh, Kaushal
Addeo, Alfredo
Funding for this research was provided by:
University of Lausanne
Article History
Accepted: 26 June 2023
First Online: 30 August 2023
Declarations
:
: Martina Imbimbo reports compensation advisory board fees from Immatics. Laureline Wetterwald declares no conflict of interest. Alex Friedlaender reports consulting fees from Roche, Pfizer, Astellas, AstraZeneca, MSD, Sanofi, Novartis, and BMS. Parikh Kaushal reports consulting fees from Jazz Pharmaceuticals and Guardant Health and speaker fees from MGH Life Sciences. Alfredo Addeo reports consulting fees from Amgen, AstraZeneca, Roche, Astellas, Takeda, BMS, MSD, Pfizer, Merck, and Novartis; speaker’s bureau fees from Novartis and Amgen.
: This article does not contain any studies with human or animal subjects performed by any of the authors.